SCHEMBL9004937

SCHEMBL9004937

CCN1c2ncccc2C(=S)Nc2c(C)cc(C)nc21

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.42
CYP2C19 P33261 5/20 0.42
CYP2C9 P11712 4/20 0.42
CYP1A2 P05177 3/20 0.40
CYP2D6 P10635 2/20 0.40
POLB P06746 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
MAPK1 P28482 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PDE3A Q14432 1/20 0.35
MAPT P10636 1/20 0.33
KDM4E B2RXH2 1/20 0.32
PDE1A P54750 1/20 0.31
PDE1B Q01064 1/20 0.31
PDE1C Q14123 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8300301 0.87 CYP2C9 (0.53) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8305357 0.82 CYP3A4 (0.39) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8305359 0.82 CYP3A4 (0.39) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8305177 0.81 CYP3A4 (0.38) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8305178 0.81 CYP3A4 (0.38) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8887366 0.76 ALDH1A1 (0.48) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8888835 0.75 ALDH1A1 (0.47) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8303477 0.75 CYP2C9 (0.58) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8887469 0.75 ALDH1A1 (0.47) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6
SCHEMBL8891082 0.75 ALDH1A1 (0.47) CYP3A4CYP2C19CYP2C9CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0498290-B1 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1996-09-18 EP disclosed
US-5550117-A HIV-1 REVERSE TRASNCRIPTASE INHIBITOR, USEFUL FOR TREATMENT OF ACQUIRED IMMUNE DIFFICIENCY SYNDROME BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-08-27 US disclosed
EP-0498290-A1 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1992-08-12 EP disclosed